Alterations in Cell Cycle Control During Tumor Progression: Effects on Apoptosis and the Response to Therapeutic Agents

  • R. J. Muschel
  • W. G. McKenna
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 213/2)


It has long been apparent that alterations in the control of the cell cycle accompany the development of tumorigenicity. The mere observation that cell growth continues in tumors whereas normal cells for the most part cease dividing and retain a diploid amount of DNA suggests that the controls regulating the normal cell cycle have failed to function in the tumor cell. In recent years the biochemical mechanisms underlying the transitions through the cell cycle have begun to be identified, and some of the gene products that are mutated in cancer cells have been shown to interact directly with these genes in control of the cell cycle. These mutated genes, as well as the cell cycle regulators, have been shown to affect whether cells undergo programmed cell death and to influence how cells respond to DNA-damaging agents that are frequently used therapeutically. Thus the genetic changes in the cell that affect cell cycle progression also have a bearing on the therapeutic outcome. While the description of the changes affecting the G0 to G1 to S phase transition is currently better understand as regards malignancy, the G2/M to phase transition also has important implications for therapy.


Cell Cycle Control Malignant Mesothelioma Nitrogen Mustard Familial Melanoma Affect Cell Cycle Progression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92: 8493–8497PubMedCrossRefGoogle Scholar
  2. Aloni-Grinstein R, Schwartz D, Rotter V (1995) Accumulation of wild type p53 protein upon gamma irradiation induces a G2 arrest-dependent immunoglobulin kappa light chain gene expression. EMBO J 14: 1392–1401PubMedGoogle Scholar
  3. Amati B, Land H (1994) Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Biol 4: 102–108Google Scholar
  4. Amati A, Littlewood TD, Evan Gl, Land H (1993) The c-myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 12: 5083–5087PubMedGoogle Scholar
  5. Bernhard EJ, Maity A, Muschel RJ, McKenna WG (1994) Increased expression of cyclin B1 mRNA coincides wirth diminished G2-phase arrest in irradiated HeLa cells treated with staurosporine or caffeine. Radiat Res 140: 393–400PubMedCrossRefGoogle Scholar
  6. Bernhard EJ, Muschel RJ, Bakanauskas VJ, McKenna WG (1996) Reducing the radiation-induced G2 delay causes HeLa cells to undergo apoptosis instead of mitotic death. Int J Radiat Biol (in press)Google Scholar
  7. Bosch F, Jares P, Campo E, Lopez-Guillrtmo A, Piris M, Villsmor N, Tassies D, Jaffe E, Monstserrat E, Rozaman C, Cardesa A (1994) PRAD-1/Cyclin D1 gene overexpression in chronic lymphoprolifera- tive disorders: a highly specific marker of mantle cell lymphoma. Blood 84: 2726–2732PubMedGoogle Scholar
  8. Busse P, Bose S, Jones R, Tolmach L (1977) The action of caffeine on X-irradiated HeLa cells. II. Synergistic lethality. Radiat Res 71: 666–667PubMedCrossRefGoogle Scholar
  9. Callender T, el-Naggar A, Lee M, Frankenthaler R, Luna M, Batsakis J (1994) PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152–158PubMedCrossRefGoogle Scholar
  10. Cheng J, Jhanwar S, Klein W, Bell D, Lee W-C, Altomare D, Nobori T, Olopade O, Buckler A, Testa J (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547–5551PubMedGoogle Scholar
  11. Deng G, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21 cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684PubMedCrossRefGoogle Scholar
  12. Desai D, Wessling H, Fisher R, Morgan D (1995a) Effects of phosphorylation by CAK on cyclin binding by cdc2 and cdk2. Mol Cell Biol 15: 345–350PubMedGoogle Scholar
  13. Desai D, Wessling H, Fisher R, Morgan D (1995b) Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2. Mol Cell Biol 15: 345–350PubMedGoogle Scholar
  14. Doree M, Galas S (1994) The cyclin-dependent protein kinases and the control of cell division. FASEB J 8: 1114–1121PubMedGoogle Scholar
  15. Dynlacht B, Flores O, Lees J, Harlow E (1994) Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 8: 1772–1786PubMedCrossRefGoogle Scholar
  16. Eilers M, Schirm S, Bishop JM (1991) The myc protein activates transcription of the alpha-prothymosin gene. EMBO J 10: 133–141PubMedGoogle Scholar
  17. el-Deiry W, Tokino T, Velculescu V, Levy D, Parson R, Trent J, Lin D, Mercer W, Kinzler K, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor supression. Cell 75: 817–825PubMedCrossRefGoogle Scholar
  18. Evan Gl, Littlewood TD (1993) The role of c-myc in cell growth. Curr Opin Genet Dev 3: 44–49PubMedCrossRefGoogle Scholar
  19. Evan Gl, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119–128PubMedCrossRefGoogle Scholar
  20. Fan SJ, Smith ML, Rivet DJ, Duba D, Zhan QM, Kohn KW, Fornace AJ, O’Connor PM (1995) Disruption of p53 function sensitizes breast cancer MCF7 cells to cisplatin and pentoxifylline. Cancer Res 55: 1649–1654PubMedGoogle Scholar
  21. Fornace A, Alamo I, Hollander M (1989a) DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800–8804CrossRefGoogle Scholar
  22. Fornace A, Nebert D, Hollander M, Leuthy J, Papathanasiou M, Fargnoli J, Holbrook N (1989b) Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents. Mol Cell Biol 9: 4196–4203PubMedGoogle Scholar
  23. Gould K, Moreno S, Owen D, Sazer S, Nurse P (1991) Phosphorylation at thr 167 is required for schizosaccharomyces pombe p34cdc2 function. EMBO J 10: 3297–3309PubMedGoogle Scholar
  24. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B, Liebermann DA (1995) p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 11: 2263–2270Google Scholar
  25. Hannon GJ, Beach D (1994) p15 (INK4B) is a potential effector of TGF-beta induced cell cycle arrest. Nature 371: 257–261PubMedCrossRefGoogle Scholar
  26. Harper JW, Adami GR, Wei N, Keyomarcki K, Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinases. Cell 75: 805–816PubMedCrossRefGoogle Scholar
  27. Harrington EA, Bennett MR, Fanidi A, Evan Gl (1994a) c-Myc-induced apoptosis in fibroblasts in inhibited by specific cytokines. EMBO J 13: 3286–3295PubMedGoogle Scholar
  28. Harrington EA, Fanidi A, Evan Gl (1994b) Oncogenes and cell death. Curr Opin Gene Dev 4: 120–129CrossRefGoogle Scholar
  29. He J, Allen J, Collins V, Allalunisturner M, Godbout R, Day R, James c (1994) Cdk4 amplification is an. alternative mechanism to p16 gene homozygous deletion in glioma cell-lines. Cancer Res 54: 5804PubMedGoogle Scholar
  30. Heikkila R, Schwab G, Wickstrom E, Loke S, Pluznik D, Watt R, Neckers L (1987) A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from GO to G1. Nature 328: 445–449PubMedCrossRefGoogle Scholar
  31. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241–251PubMedCrossRefGoogle Scholar
  32. Hunter T, Pines J (1994) Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573–582CrossRefGoogle Scholar
  33. Hussussian C, Struewing J, Goldstein A, Higgins P, Ally D, Sheahan M, Clark W, Tucker M, Dracopoli N (1994) Germline p16 mutations in familial melanoma. Nature Genet 8: 15–21PubMedCrossRefGoogle Scholar
  34. Igaki H, Sasaki H, Kishi T, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Sugimura T, Terada M (1994) Highly frequent homozygous deletion of the p16 gene in estophageal cancer cell lines. Biochem Biophys Res Commun 203: 1090–1095PubMedCrossRefGoogle Scholar
  35. Jen J, Harper J, Bigner S, Bigner D, Papadopoulos N, Markowitz S, Willson J, Kinzler K, Vogelstein B (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res 54: 6353–6358PubMedGoogle Scholar
  36. Jiang H, Lin J, Su Z, Collart F, Huberman E, Fisher P (1994) Induction of differentiation in human promyelocytic HL-60 leukemia cell activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397–3406PubMedGoogle Scholar
  37. Kamb A, Gruis N, Weaverfeldhaus J et al. (1994a) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440PubMedCrossRefGoogle Scholar
  38. Kamb A, Shattuckeidens D, Eeles R et al. (1994b) Analysis of the p16 gene (cdkn2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genet 8: 22–26CrossRefGoogle Scholar
  39. Kane DJ, Safafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262: 1274–1277PubMedCrossRefGoogle Scholar
  40. Kastan M, Zhan Q, el-Deiry W, Carrier F, Jacks T, Walsh W, Plunkett B, Vogelstein B, Fornace A (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia- telangiectasia. Cell 71: 587–597PubMedCrossRefGoogle Scholar
  41. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304–6311PubMedGoogle Scholar
  42. Kato J-Y, Matusushime H, Hiebert S, Ewen M, Sherr C (1993) Direct binding of cyclin D to the retinoblastoma gene product (PRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331–342PubMedCrossRefGoogle Scholar
  43. Keyomarsi K, Pardee A (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112–1116PubMedCrossRefGoogle Scholar
  44. King RW, Jackson PK, Kirschner MW (1994) Mitosis in transition. Cell 79: 563–570PubMedCrossRefGoogle Scholar
  45. Krek W, Marks J, Schmitz N, Nigg E, Simanis V (1992) Vertebrate p34cdc2 phosphorylation site mutants: effects upon cell cycle progression in the fission yeast Schizosaccharomyces pombe. J Cell Sci 102: 43–53PubMedGoogle Scholar
  46. Krek W, Nigg E (1991) Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. EMBO J 10: 305–316PubMedGoogle Scholar
  47. Kuerbitz S, Plunkett B, Walsh W, Kastan M (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89: 7491–7495PubMedCrossRefGoogle Scholar
  48. Lane DP (1992) p53, guardian of the genome. Nature 358: 15–16PubMedCrossRefGoogle Scholar
  49. Lane DP (1993) A death in the life of p53. Nature 362: 786PubMedCrossRefGoogle Scholar
  50. Leach R, Elledge S, Sherr C, Willson J, Markowitz S, Kinzler K, Vogenstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986–1989PubMedGoogle Scholar
  51. Lebwoh D, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N (1994) A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925–1929Google Scholar
  52. Li R, Waga S, Hannon G, Beach D, Stillman B (1994) Differential effects by the p21 inhibitor on PCNA- dependent DNA replication and repair. Nature 37: 534–537CrossRefGoogle Scholar
  53. Li Y, Nichols M, Shay J, Xiong Y (1994) Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078–6082PubMedGoogle Scholar
  54. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923–935PubMedCrossRefGoogle Scholar
  55. Lock R (1992) Inhibition of p34 cdc2 kinase activation, tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Cancer Res 52: 1817–1822PubMedGoogle Scholar
  56. Lorca T, Labbe J, Devault A, Fesquet D, Capony J, Cavadore J, Bouffant FL, Doree M (1992) Dephosphorylation of cdc2 on threonine 161 is required for cdc2 kinase inactivation and normal anaphase. EMBO J 11: 2381–2390PubMedGoogle Scholar
  57. Lowe S, Schmitt E, Smith S, Osborne B, Jacks T (1993) P53 is required for. radiation-induced apoptosis in mouse thymocytes. Nature 362: 847–849PubMedCrossRefGoogle Scholar
  58. Maity A, McKenna WG, Muschel RJ (1994) Posttranscriptional regulation of cyclin B1 mRNA through the cell cycle and after irradiation. EMBO J 14: 603–609Google Scholar
  59. Michieli P, Chedid M, Lin D, Pierce J, Mercer W, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391–3395PubMedGoogle Scholar
  60. Morgan D (1995) Principles of CDK regulation. Nature 374: 131PubMedCrossRefGoogle Scholar
  61. Morgenbesser SD, Williams BO, Jacks T, Depinho RA (1994) p53 dependent apoptosis produced by rb deficiency in the developing mouse lens. Nature 371: 72–74PubMedCrossRefGoogle Scholar
  62. Motokura T, Bloom T, Kim H, Juppner H, Ruderman J, Kronenberg H, Arnold A (1991) A novel cyclin encoded by a bell-linked candidate oncogene. Nature 350: 512–515CrossRefGoogle Scholar
  63. Muschel R, Zhang H, Iliakis G, McKenna W (1991) Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res 51: 5113–5117PubMedGoogle Scholar
  64. Muschel R, Zhang H, McKenna W (1993) Differential effect of ionizing radiation on the expression of cyclin A and cyclin B in Hela cells. Cancer Res 53: 1–8Google Scholar
  65. Muschel R, Bernhard E, Garza L, McKenna W, Koch C (1995) Induction of apoptosis at different oxygen tensions: evidence that oxygen radicals do not mediate apoptotic signalling. Cancer Res 55: 995–998PubMedGoogle Scholar
  66. Musgrove E, Lee C, Buckley M, Sutherland R (1994) Cyclin D1 induction in breast cancer cells shortens G, and is sufficient for cells arrested in G, to complete the cell cycle. Proc Natl Acad Sci USA 91: 8022–8026PubMedCrossRefGoogle Scholar
  67. Norbury C, Nurse P (1992) Animal cell cycles and their control. Annu Rev Biochem 61: 441–470CrossRefGoogle Scholar
  68. Nunez G, Seto M, Seremetis S, Ferrero D, Grignani F, Korsmeyer S, Favera RD (1989) Growth and tumor promoting effects of deregulated bcl2 in human B-lymphoblastoid cells. Proc Natl Acad Sci USA 86: 4589–4593PubMedCrossRefGoogle Scholar
  69. O’Connor PM, Ferris DK, White GA, Pines J, Hunter T, Longo DL, Kohn KW (1992) Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard. Cell Growth Differ 3: 43–52PubMedGoogle Scholar
  70. O’Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW (1993) G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem 268: 8298–8308PubMedGoogle Scholar
  71. O’Connor PM, Ferris DK, Hoffman I, Jackman J, Draetta G, Kohn KW (1994) Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard in human lymphoma cells. Proc Natl Acad Sci USA 91: 9480–9484PubMedCrossRefGoogle Scholar
  72. Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H (1994) Homozygous loss of the cyclin-dependent kinase 4-inhibitor (P16) gene in human leukemias. Blood 84: 2431–2435PubMedGoogle Scholar
  73. Okamoto A, Demetrick D, Spillare E, Hagiwara K, Hussain S, Bennett W, Forrester K, Gerwin B, Serrano M, Beach D, Harris C (1994) Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045–11049PubMedCrossRefGoogle Scholar
  74. Oren M (1992) The involvement of oncogenes and tumor suppressor genes in the control of apoptosis. Cancer Metastasis Rev 11: 141–148PubMedCrossRefGoogle Scholar
  75. Osteen K, Rodgers W, Gaire M, Hargrove J, Gorstein F, Matrisian L (1994) Stromalepithelial interaction mediatesteroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 91: 10129–10133PubMedCrossRefGoogle Scholar
  76. Otterson G, Kratzke R, Coxon A, Kim Y, Kaye F (1994) Absence of p16ink4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375–3378PubMedGoogle Scholar
  77. Palayoor S, Macklis R, Bump E, Coleman C (1995) Modulation of radiation-induced apoptosis and G(2) M block in murine T-lymphoma cells. Radiat Res 141: 235–243PubMedCrossRefGoogle Scholar
  78. Pan HC, Griep AE (1994) Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice- implications for tumor-suppressor gene function in development. Genes Dev 8: 1285–1299PubMedCrossRefGoogle Scholar
  79. Polyak K, Kato J-Y, Solomon M, Sherr C, Massague J, Roberts J, Koff A (1994a) p27Kip1- a cyclin-Cdk inhibitor, links transforming growth factor-p and contact inhibition to cell cycle arrest. Genes Dev 8: 9–22PubMedCrossRefGoogle Scholar
  80. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts J, Tempst P, Massague J (1994b) Cloning of p27Klp1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66PubMedCrossRefGoogle Scholar
  81. Powell SN, Defrank JS, Connell P, Edgan M, Preffer F, Dombkowski D, Tang W, Friend S (1995) Differential sensitivity of p53- and p53+ cells to caffeine-induced radiosensitization and override of G (2) delay. Cancer Res 55: 1643–1648PubMedGoogle Scholar
  82. Reed JC (1994) Mini-review: cellular mechanisms of disease series. J Cell Biol 124: 1–6PubMedCrossRefGoogle Scholar
  83. Reed J, Cuddy M, Haldar S, Croce C, Nowell P, Makover D, Bradley K (1990) Bcl-2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with myc and inhibition by bc12 antisense. Proc Natl Acad Sci USA 87: 3660–3664PubMedCrossRefGoogle Scholar
  84. Resnitzky D, Gossen M, Bujard H, Reed S (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 14: 1669–1679PubMedGoogle Scholar
  85. Russell KJ, Wiens LW, Demers GW, Galloway DA, Plon SE, Groudine M (1995) Abrogation of the G(2) checkpoint results in differential radiosensitization of G(1) checkpoint deficient and G(1) checkpoint- competent cells. Cancer Res 55: 1639–1642PubMedGoogle Scholar
  86. Schmidt E, Ichimura K, Reifenberger G, Collins V (1994) CDKN2 (p16/MTS1) gene deletion of CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 54: 6321–6324PubMedGoogle Scholar
  87. Serrano M, Hannon G Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704PubMedCrossRefGoogle Scholar
  88. Sheikh M, Li X-S, Chen J-C, Shao Z-M, Ordonez J, Fontana J (1994) Mechanisms of regulation of WAF1/ Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9: 3407–3415PubMedGoogle Scholar
  89. Sherr C (1993) Mammalian G1, cyclins. Cell 73: 1059–1065CrossRefGoogle Scholar
  90. Sherr C (1994) G1 phase progression: cycling on cue. Cell 79: 551–555PubMedCrossRefGoogle Scholar
  91. Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T(1992) IL-2 and EGF receptors stimulate the homatopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 70: 57–67PubMedCrossRefGoogle Scholar
  92. Shirodkar S, Ewen M, DeCapro J, Morgan J, Livingston D, Chittenden T (1992) The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68: 157–166CrossRefGoogle Scholar
  93. Sicinski P, Donaher JL, Parker SB, Li TS, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82: 621–630PubMedCrossRefGoogle Scholar
  94. Slingerland J, Hengst L, Pan G-H, Alexander D, Stampfer M, Reed S (1994) A novel inhibitor of cyclin- cdk activity detected in transforming growth factor (3-arrested epithelial cells. Mol Cell Biol 14: 3683–3694PubMedGoogle Scholar
  95. Smith M, Chen I, Zhan Q, Bae I, Chen C, Gilmer T, Kastan M, OConnor P, Fornace A (1994) Interaction of the p53-regulated protein GADD45 with proliferating cell nuclear antigen. Science 266: 1376–1380PubMedCrossRefGoogle Scholar
  96. Stewart N, Hicks GG, Paraskevas F, Mowat M (1995) Evidence for a second cell cycle block at G2/M by p53. Oncogene 10: 109–115PubMedGoogle Scholar
  97. Strasser A, Harris A, Bath M, Cory S (1990) Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348: 331–333PubMedCrossRefGoogle Scholar
  98. Telford WG, King LE, Fraker PJ (1991) Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 24: 447–459PubMedCrossRefGoogle Scholar
  99. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67–74PubMedCrossRefGoogle Scholar
  100. Wang J, Chenivesse X, Henglein B, Brechot C (1990) Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555–557PubMedCrossRefGoogle Scholar
  101. Weaverfeldhaus J, Guirs N, Neuhausen S, Lepaslier D, Stockert E, Skolnick M, Kamb A (1994) Localization of a putative tumor-suppressor gene by using homozysgous deletions in melanomas. Proc Natl Acad Sci USA 1994: 7563–7567CrossRefGoogle Scholar
  102. Weinert TA, Hartwell LH (1988) The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317–322PubMedCrossRefGoogle Scholar
  103. White E (1993) Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. PSEBM 204: 30–39Google Scholar
  104. White E (1994) P53, guardian of rb. Nature 371: 21–22PubMedCrossRefGoogle Scholar
  105. Xiong Y, Zhang H, Beach D (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572–1583PubMedCrossRefGoogle Scholar
  106. Xu M, Sheppard K-A, Peng C-Y, Yee A, Piwnica-Worms H (1994) Cyclin A/CDK2binds directly to E2F-1 and inhibits the dna N-binding activity of E2F-1/DP-1 by phosphorylation. Mol Cell Biol 14: 8420–8431PubMedGoogle Scholar
  107. Yamada T, Ohyama H (1988) Radiation-induced interphase death of rat thymocytes is internally programmed (apoptosis). Int J Radiat Biol 53: 65–75CrossRefGoogle Scholar
  108. Zeigler A, Jonason A, Leffell D, Simon J, Sharma H, Kimmelman J, Remington L, Jacks T, Brash D (1994) Sunburn and p53 in the onset of skin cancer. Nature 372: 773–776CrossRefGoogle Scholar
  109. Zeigler A, Leffell D, Kunala S, Sharma H, Gailani M, Simon J, Halgerin A, Baden H, Shapiro P, Bale A, Brash D (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90: 4216–4220CrossRefGoogle Scholar
  110. Zhang H, Hannon G, Beach D (1994) p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8: 1750–1758PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • R. J. Muschel
    • 1
  • W. G. McKenna
    • 2
  1. 1.Department of Pathology and Laboratory MedicineUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Department of Radiation OncologyUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations